Breast Cancer Flashcards

1
Q

How are pre and post-menopausal women treated differently with hormone therapies in breast cancer?

A

Pre-menopausal: Tamoxifen

Post-menopausal: Aromatase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When to begin BRCA1/BRCA2 screening and what to also include?

A
  • Should begin at 25 or five years before youngest relative diagnosed
  • Should include MRI and mammogram alternating
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A patient with early breast cancer is found to have a tumor larger than 1cm that is triple negative, what treatment should be considered in addition to surgery and radiation?

A

All triple negative breast cancer with tumor >1cm should consider chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Early breast cancer treatment

A

Surgery + radiation
or
Radical mastectomy if patient fears recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adjuvant hormone therapy used in breast cancer that prevents conversion of testosterone to estrogen

A

Aromatase inhibitors

(anastrozole, letrozole, exemestane)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

True or false. In stage three breast cancer a modified radical mastectomy is never a necessity

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Two side effects of tamoxifen

A
  • Thromboembolic disease
  • Endometrial cancer

(mostly in women over 50)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are estrogen positive and estrogen negative metastatic breast cancers treated differently?

A

Estrogen positive: Hormone therapy

Estrogen negative: Chemo/immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lifestyle changes to prevent breast cancer

A
  • Minimize post-menopausal obesity
  • Regular exercise
  • Abstinence from alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name for pre-breast cancer

A

In situ carcinoma

(most are ductal = DCIS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Estrogen positive and estrogen negative/HER2 positive breast cancers tend to metastasize to different locations. Where are they?

A

Estrogen positive: bone metastasis

Estrogen negative/HER2 positive: visceral metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Is the presence of estrogen/progesterone receptors on a breast cancer tumor a good or bad prognostic factor?

A

Good
- Estrogen/progesterone causes these tumors to grow.
- Hormone therapy can block estrogen and progesterone to stop these tumors from growing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Methods for diagnosis and staging of breast cancer

A

Dx: Fine needle aspiration/core-needle biopsy

Staging: MRI both breasts, evaluate lymph nodes, if lymph nodes suspicious then PET scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk factors for breast cancer (many)

A
  • Advancing age, female gender, white
  • Post-menopausal obesity
  • Reproductive factors: early menarche, late first pregnancy, late menopause, nulliparity
  • Environmental: Prolonged use of HRT, consumption of alcohol
  • Family history
  • Germline mutations (BRCA1 and BRCA2, p53, PTEN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tamoxifen alternative with less risk of endometrial cancer

A

Raloxifene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatments for stage three breast cancer

A
  • Surgery, if resectable
  • All get chemotherapy
  • All get radiation
  • Hormone therapy if tumor expresses estrogen/progesterone
17
Q

Medication used in breast cancer prophylaxis which prevents estrogen from reaching breast tissue

A

Tamoxifen

18
Q

Is the presence of HER2 proteins on a breast cancer tumor a good or bad prognostic factor?

A

Bad
- HER2 = human epidermal growth factor receptor 2
- These tumors are more likely to grow faster, spread to other parts of the body, and come back after treatment

(but better than triple negative, since HER2 can be targeted with treatments)